Literature DB >> 6487484

Thiazide-induced hypokalaemia; prevalence higher in women.

J M Toner, L E Ramsay.   

Abstract

In 193 hypertensive patients taking bendrofluazide 5 mg daily, the mean serum potassium concentration was lower in women than in men (3.77 vs 3.99 mmol/l, P less than 0.001) and the prevalence of hypokalaemia (less than 3.5 mmol/l) was higher (25% vs 12%, P less than 0.05). This difference between the sexes was independent of age, body weight, renal function, the use of other antihypertensive drugs and compliance with treatment as judged by tablet counts. Severe hypokalaemia (less than 3.0 mmol/l) was uncommon and showed no difference between the sexes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487484      PMCID: PMC1463655          DOI: 10.1111/j.1365-2125.1984.tb02488.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Diuretic therapy and hypokalemia in geriatric out-patients.

Authors:  R Krakauer; M Lauritzen
Journal:  Dan Med Bull       Date:  1978-04

2.  A comparison of the effects of hydrochlorothiazide and of frusemide in the treatment of hypertensive patients.

Authors:  J Anderson; B E Godfrey; D M Hill; A D Munro-Faure; J Sheldon
Journal:  Q J Med       Date:  1971-10

3.  Severe hypokalemia in hospitalized patients.

Authors:  D H Lawson; D A Henry; J M Lowe; J M Gray; H G Morgan
Journal:  Arch Intern Med       Date:  1979-09

4.  Amelioration of bendrofluazide-induced hypokalemia by timolol.

Authors:  J Hettiarachchi; L E Ramsay; D L Davies; R Fraser; W S Watson
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

5.  Acute transient hypokalaemia: new interpretation of a common event.

Authors:  D B Morgan; R M Young
Journal:  Lancet       Date:  1982-10-02       Impact factor: 79.321

6.  Factors influencing serum potassium in treated hypertension.

Authors:  L E Ramsay; P Boyle; M H Ramsay
Journal:  Q J Med       Date:  1977-10

7.  Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.

Authors:  L E Ramsay; J Hettiarachchi; R Fraser; J J Morton
Journal:  Clin Pharmacol Ther       Date:  1980-04       Impact factor: 6.875

8.  Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.

Authors:  P R Jackson; L E Ramsay; V Wakefield
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

9.  Hypokalaemia and diuretics: an analysis of publications.

Authors:  D B Morgan; C Davidson
Journal:  Br Med J       Date:  1980-03-29

10.  Female preponderance in diuretic-associated hypokalemia: a retrospective study in seven long-term care facilities.

Authors:  B G Clark; R Wheatley; J L Rawlings; R E Vestal
Journal:  J Am Geriatr Soc       Date:  1982-05       Impact factor: 5.562

View more
  9 in total

Review 1.  Pathophysiology and management of hypokalemia: a clinical perspective.

Authors:  Robert J Unwin; Friedrich C Luft; David G Shirley
Journal:  Nat Rev Nephrol       Date:  2011-02       Impact factor: 28.314

2.  Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Authors:  Vicente E Torres; Arlene B Chapman; Ronald D Perrone; K Ty Bae; Kaleab Z Abebe; James E Bost; Dana C Miskulin; Theodore I Steinman; William E Braun; Franz T Winklhofer; Marie C Hogan; Frederic R Oskoui; Cass Kelleher; Amirali Masoumi; James Glockner; Neil J Halin; Diego R Martin; Erick Remer; Nayana Patel; Ivan Pedrosa; Louis H Wetzel; Paul A Thompson; J Philip Miller; Catherine M Meyers; Robert W Schrier
Journal:  Kidney Int       Date:  2011-12-28       Impact factor: 10.612

3.  Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients.

Authors:  J M Toner; L A Brawn; W W Yeo; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 4.  Adverse drug reactions. An overview of special considerations in the management of the elderly patient.

Authors:  L A Brawn; C M Castleden
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

Review 5.  Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients.

Authors:  A Baglin; J C Boulard; T Hanslik; J Prinseau
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

6.  Pharmacokinetics of potassium chloride in wax-based and syrup formulations.

Authors:  J M Toner; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

Review 7.  Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Authors:  A W Hoes; D E Grobbee; T M Peet; J Lubsen
Journal:  Drugs       Date:  1994-05       Impact factor: 9.546

8.  Community-acquired hypokalemia in elderly patients: related factors and clinical outcomes.

Authors:  S Bardak; K Turgutalp; M B Koyuncu; H Harı; I Helvacı; D Ovla; M Horoz; S Demir; A Kıykım
Journal:  Int Urol Nephrol       Date:  2016-12-29       Impact factor: 2.370

9.  Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage.

Authors:  Shinji Fukui; Hiroshi Katoh; Nobusuke Tsuzuki; Shoichiro Ishihara; Naoki Otani; Hidetoshi Ooigawa; Terushige Toyooka; Akira Ohnuki; Takahito Miyazawa; Hiroshi Nawashiro; Katsuji Shima
Journal:  Crit Care       Date:  2003-02-21       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.